The Devyser blog

"Devyser reports yet another quarter of record sales and strong gross margins. The positive sales...

Devyser announces its decision to establish a CLIA lab in Atlanta, Georgia, USA. By operating a...

Safety: what comes to mind when you hear that word? Keeping your loved ones safe? You probably ask...

Growth. We are building for growth and consequently, we are excited to announce the launch of our...

We are very happy to announce that TÜV SÜD has verified the update of our quality management system...

Early non-invasive prenatal testing (NIPT) for fetal Rhesus D (RHD) status is playing an...

MSS, Mexico’s largest public health care provider and INP, Mexico’s National Institute of...

Stockholm, February 2, 2021

Non-invasive prenatal testing (NIPT) can help us determine fetal RhD status without a drop of fetal...

Staffing requirements

Thalassemia is typically caused by sequence variants in the HBA1, HBA2 or HBB genes. The common...

Swedish molecular diagnostics company Devyser, announced today at the 45th annual European Bone...